A detailed history of Cva Family Office, LLC transactions in Repligen Corp stock. As of the latest transaction made, Cva Family Office, LLC holds 4 shares of RGEN stock, worth $587. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4
Holding current value
$587
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$119.79 - $167.35 $479 - $669
4 New
4 $0
Q2 2022

Jul 11, 2022

SELL
$140.68 - $188.02 $8,440 - $11,281
-60 Closed
0 $0
Q4 2021

Jan 25, 2022

BUY
$247.59 - $304.47 $14,855 - $18,268
60 New
60 $16,000
Q3 2021

Oct 12, 2021

SELL
$194.77 - $324.21 $14,607 - $24,315
-75 Closed
0 $0
Q2 2021

Jul 13, 2021

BUY
$165.87 - $220.95 $12,440 - $16,571
75 New
75 $15,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.15B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Cva Family Office, LLC Portfolio

Follow Cva Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cva Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cva Family Office, LLC with notifications on news.